MedTrace Logo

Utilizing Glycaemic Index: An Investigation of the Glycaemia and Cognition in Type 2 Diabetes

NCT03360604 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-10-08

No results posted yet for this study

Summary

The current study aims to investigate the effects of two GI diets (low vs. high GI) in a sample (25 participants) that has diet controlled type 2 diabetes. This sample has been chosen as those with diabetes have been shown to suffer with poor glucose tolerance, along with the associated deficits such as compromised cognitive function. Therefore, it is expected that differences produced by the two diets on blood glucose concentrations and cognitive performance will be greater than those previously seen. If this is the case after analyzing the results, it will provide a potential strategy (diet) for improving glucose tolerance and cognitive performance in a vulnerable section of the population.

Conditions

Interventions

DIETARY_SUPPLEMENT

Low Glycaemic Diet

This intervention is a diet consisting of a Low GI breakfast, lunch and snack meal.

DIETARY_SUPPLEMENT

High Glycaemic Diet

This intervention is a diet consisting of a High GI breakfast, lunch and snack meal.

Sponsors & Collaborators

  • Matthew Grout

    lead OTHER

Principal Investigators

  • Daniel J Lamport, PhD · University of Reading

  • Matthew J Grout, PhD · University of Reading

  • Julie A Lovegrove, PhD · University of Reading

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-04
Primary Completion
2018-12-01
Completion
2018-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03360604 on ClinicalTrials.gov